1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Recommendations for Deprescribing of Medication in the Last Phase of Life : An International Delphi Study
- Contribution to journal › Article
-
Mark
Parenteral Hydration in Dying Patients With Cancer : A National Registry Study
- Contribution to journal › Article
- 2023
-
Mark
Should Benzodiazepines be Used for Reducing Dyspnea in Patients with Advanced Illnesses?
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Improving Serious Illness Communication : Testing the Serious Illness Care Program with Trainees
- Contribution to journal › Article
-
Mark
Dyspnoea-12 and Multidimensional Dyspnea Profile : Systematic Review of Use and Properties
- Contribution to journal › Scientific review
-
Mark
Minimally Clinically Important Improvements (MCII) and Worsening (MCIW) in Symptoms
- Contribution to journal › Letter
- 2020
-
Mark
Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial
- Contribution to journal › Article
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
- Contribution to journal › Article
-
Mark
Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer : A Prospective Longitudinal Multinational Study (EPCCS)
- Contribution to journal › Article
-
Mark
Breathlessness, Anxiety, Depression, and Function–The BAD-F Study : A Cross-Sectional and Population Prevalence Study in Adults
- Contribution to journal › Article
